Clinical Trial Update: Neoadjuvant Lurbinectedin and Preoperative Radiation for Treating Soft Tissue Sarcomas [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of neoadjuvant lurbinectedin with preoperative radiation for locally advanced soft tissue sarcoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Lurbinectedin (lurbinectedin)

Snippet

Sponsor: University of California, San Francisco | Conditions: Locally Advanced Soft Tissue Sarcoma | Phase 1, Phase 2 | Status: WITHDRAWN